FEED the BULL

Welcome to Feed the Bull - A home for investment information and interaction.

Tag: Rigel

Sort
E.g., 2013-06-19
E.g., 2013-06-19
Enter a comma separated list of user names.

Rigel Pharmaceuticals, Inc (NASDAQ:RIGL) reported financial results for the fourth quarter and year ended December 31, 2010. For the fourth quarter of 2010, Rigel reported a net loss of $17.2 million, or $0.33 per share, compared to a net loss of $25.1 million, or $0.48 per share, in the fourth quarter of 2009.

Enzo Biochem (NYSE:ENZ) is a leading life sciences and biotechnology company focused on harnessing genetic processes to develop research tools, diagnostics and therapeutics and provides reference laboratory services to the medical community.

ADVERTISE WITH US